Breakthrough findings out of Carnegie Mellon University on how parts of the brain interpret touch, and the body’s reactions ...

Spinogenix, Inc., a clinical-stage biopharmaceutical company developing first-in-class synaptic regenerative and corrective therapeutics, today announced it has been awarded "Regenerative Therapeutics ...

Researchers at VIB and KU Leuven have uncovered how mutations in the ASPM gene disrupt the development of neural stem cells ...